Fischer cleared for interstitial breast brachytherapy

Fischer Imaging has received FDA clearance to use its MammoTest digital breast biopsy system for interstitial breast brachytherapy.

Interstitial brachytherapy is a less-invasive, four-day alternative to the traditional six-week external-beam radiation therapy for breast tumors, according to the Denver-based firm. While traditional radiation therapy irradiates the entire breast, brachytherapy uses x-ray guidance, such as provided by the MammoTest system, to insert catheters for irradiation of the tissue within 2 cm of a lumpectomy site.

By staff writers
December 2, 2004

Related Reading

Fischer grows revenues, settles with SEC, November 16, 2004

Road to RSNA, Fischer Imaging, November 10, 2004

Balloon brachytherapy suitable alternative to standard breast cancer radiation, June 15, 2004

Copyright © 2004

Page 1 of 569
Next Page